Skip to content

Cardiology researchers at Stanford Medicine are increasingly turning to CRISPR to understand -- and maybe one day -- treat heart disease.

Cardiology researchers at Stanford Medicine are increasingly turning to CRISPR to understand -- and maybe one day -- treat heart disease.

Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.

Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.